Publications

5808 Results

Predictors of survival in advanced renal cell carcinoma (RCC): long-term results from Southwest Oncology Group trial S8949

Authors
S Conlon;CM Tangen;RC Flanigan;ED Crawford
Journal / Conference
Journal of Clinical Oncology 26(15S):260s, #5042
Year
2008
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8949

An update of pharmacogenetic analysis of adjuvant rectal cancer patients treated with 5-Fluorouracil and pelvic radiation in a phase III intergroup trial (INT-0144, SWOG 9304)

Authors
W Zhang;C Rankin;KD Danenberg;JK Benedetti;PV Danenberg;CM Ulrich;RS Holmes;KW Makar;CD Blanke;SR Smalley;HJ Lenz
Journal / Conference
Journal of Clinical Oncology 26(15S):206s, #4115
Year
2008
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9304 (INT-0144)

Use of prostate-specific antigen progression (PSA-P) to predict overall survival (OS) in patients (pts) with metastatic prostate cancer (PC): data from S9346 and S9916

Authors
MHA Hussain;B Goldman;CM Tangen;C Higano;DP Petrylak;ED Crawford
Journal / Conference
Journal of Clinical Oncology 26(15S):253s, #5015
Year
2008
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9346

Polymorphisms in folate-metabolizing enzymes and response to 5-fluorouracil among stage II or III rectal cancer pataients (SWOG 9304)

Authors
RS Holmes;C Rankin;KW Makar;JK Benedetti;SR Smalley;CD Blanke;HJ Lenz;CM Ulrich
Journal / Conference
Proceedings of the American Association for Cancer Research, abst. 4797
Year
2008
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9304 (INT-0144)

Long-term survival with gelfitinib (ZD1839) therapy for advanced bronchioalveolar lung cancer (BAC). Southwest Oncology Group Study S0126

Authors
HL West;K Chansky;WA Franklin;D Hirsch;JJ Crowley;DH Lau;DR Gandara
Journal / Conference
Journal of Clinical Oncology 26(15S):435s, #8047
Year
2008
Research Committee(s)
Lung
Study Number(s)
S0126

A sequential treatment approach to muscle-invasive urothelial cancer - a phase II Southwest Oncology Group trial (S0219) of neoadjuvant paclitaxel, carboplatin, and gemcitabine (PCG)

Authors
PN Lara;B Goldman;RW de Vere White;CM Tangen;DC Smith;DP Wood;M Hussain;ED Crawford
Journal / Conference
Journal of Clinical Oncology 26(15S):255s, #5022
Year
2008
Research Committee(s)
Genitourinary
Study Number(s)
S0219

A randomized Southwest Oncology Group study comparing dexamethasone (D) to lenalidomide + dexamethasone (LD) as treatment of newly-diagnosed multiple myeloma (NDMM): impact of cytogenetic abnormalities on efficacy of LD, and updated overall study results

Authors
JA Zonder;JJ Crowley;V Bolejack;MA Hussein;DF Moore;B Whittenberger;MH Abidi;BG Durie;B Barlogie
Journal / Conference
Journal of Clinical Oncology 26(15S):459s, #8521
Year
2008
Research Committee(s)
Myeloma
Study Number(s)
S0232

Cetuximab as second-line therapy in patients with metastatic esophageal cancer: a phase II Southwest Oncology Group study

Authors
PJ Gold;B Goldman;S Iqal;LP Leichman;HJ Lenz;CD Blanke
Journal / Conference
Journal of Clinical Oncology 26(15S):222s, #4536
Year
2008
Research Committee(s)
Gastrointestinal
Study Number(s)
S0415

Phase II intergroup study of sorafenib (s) in advanced soft tissue sarcomas (STS) SWOG 0505

Authors
CW Ryan;M von Mehren;C Rankin;JR Goldblum;GD Demetri;VHC Bramwell;EC Borden
Journal / Conference
Journal of Clinical Oncology 26(15S):561s, #10532 (poster)
Year
2008
Research Committee(s)
Sarcoma
Study Number(s)
S0505

Phase II trial of combination thalidomide (thal) plus temozolomide (TMZ), (TT), in patients with metastatic malignant melanoma (MMM): Southwest Oncology Group S0508

Authors
JI Clark;J Moon;LF Hutchins;JA Sosman;WM Kast;DM Da Silva;PY Liu;JA Thompson;VK Sondak
Journal / Conference
Journal of Clinical Oncology 26(15S):484s, #9007
Year
2008
Research Committee(s)
Melanoma
Study Number(s)
S0508